ESMO Virtual Congress 2020: Spotlight on Genitourinary Cancers

<p><span data-sheets-value= "{"1":2,"2":"<p>This week, we're hearing about three reports on genitourinary cancers presented at ESMO Virtual Congress 2020. We'll hear directly from the researchers about first-line treatment for metastatic renal cell carcinoma, as well as the long-term results of a doublet therapy for men with advanced hormone-naive prostate cancer.</p><p>To listen to more podcasts from ASCO, visit <a href=\"https://www.asco.org/about-asco/asco-digital/podcasts\">asco.org/podcasts</a>. <br></p>"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we're hearing about three reports on genitourinary cancers presented at ESMO Virtual Congress 2020. We'll hear directly from the researchers about first-line treatment for metastatic renal cell carcinoma, as well as the long-term results of a doublet therapy for men with advanced hormone-naive prostate cancer.</span></p> <p> </p>